Established in 1996, PDCI Market Access Inc. is Canada’s leading pricing and reimbursement consultancy, serving both Canadian affiliate and Global life sciences clients. Over the years, PDCI has grown to a staff of over twenty, comprised of bilingual strategic advisors, analysts and administrative staff. In recent years, PDCI has extended its geographical reach and presence in Canada by expanding to the Greater Toronto Area and Montreal. This expansion has allowed PDCI to facilitate the needs of its Toronto and Montreal clients, while still maintaining operations from its Ottawa headquarters and serving the needs of a growing global client base.
PDCI prides itself on being the only Canadian consulting firm with core competencies and expertise in Canadian pricing, market access and reimbursement strategy. We are a client focussed, mid-size consultancy that is large enough to have capacity to address unforeseen events, but not so much that our senior staff participate in all projects. PDCI has significant infrastructure, including powerful databases, scientific resources, and market intelligence.
PDCI’s projects include: payer research, pricing & reimbursement roadmaps, launch and health technology assessment (HTA) submission assessments and HTA/Payer submissions including dossiers to the Common Drug Review (CDR), pan-Canadian Oncology Drug Review (pCODR), L’Institut national d’excellence en santé et en services sociaux (INESSS) and public and private payers. Dossier work includes the development of clinical summaries, value dossiers, budget impact analyses, and health economic analyses. PDCI also develops assessments, submissions and negotiations